Loading...
Uploaded by MSF on Sep 19, 2011
Novartis is lobbying India's Supreme Court to undo a key safeguard in Indian patent law, which would have a devastating impact on access to affordable medicines across the developing world.
Nonprofits & Activism
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)